The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions
Abstract
More than 80% of patients with type 2 diabetes mellitus develop hypertension, and approx. 20% of patients with hypertension develop diabetes. This combination of cardiovascular risk factors will account for a large proportion of cardiovascular morbidity and mortality. Lowering elevated blood pressure in diabetic hypertensive individuals decreases cardiovascular events. In patients with hypertension and diabetes, the pathophysiology of cardiovascular disease is multifactorial, but recent evidence points toward the presence of an important component dependent on a low-grade inflammatory process. Angiotensin II may be to a large degree responsible for triggering vascular inflammation by inducing oxidative stress, resulting in up-regulation of pro-inflammatory transcription factors such as NF-κB (nuclear factor κB). These, in turn, regulate the generation of inflammatory mediators that lead to endothelial dysfunction and vascular injury. Inflammatory markers (e.g. C-reactive protein, chemokines and adhesion molecules) are increased in patients with hypertension and metabolic disorders, and predict the development of cardiovascular disease. Lifestyle modification and pharmacological approaches (such as drugs that target the renin–angiotensin system) may reduce blood pressure and inflammation in patients with hypertension and metabolic disorders, which will reduce cardiovascular risk, development of diabetes and cardiovascular morbidity and mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACE-I/ARBs are typically prescribed to decrease blood pressure and sympathetic activity (Savoia and Schiffrin, 2007).”
From Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond (2017) · cites this paper as Savoia and Schiffrin, 2007
In the citing paper
“there is considerable evidence that its underlying cause is inflammatory in nature [678-686]”
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,090
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Yudkin, J. S., Stehouwer, C. D. A., Emeis, J. J., & Coppack, S. W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.972 · Cited by 2,465
Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
Ridker, P. M., Rifai, N., Stampfer, M. J., & Hennekens, C. H. (2000) · Circulation · doi:10.1161/01.cir.101.15.1767 · Cited by 2,429
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133
Esposito, K., Marfella, R., Ciotola, M., Di Palo, C., Giugliano, F., Giugliano, G., D'Armiento, M., D'Andrea, F., & Giugliano, D. (2004) · JAMA · doi:10.1001/jama.292.12.1440 · Cited by 2,126
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909 · Cited by 1,984
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Current Concepts of the Pathogenesis of the Acute Coronary Syndromes
Libby, P. (2001) · Circulation · doi:10.1161/01.cir.104.3.365 · Cited by 1,558
Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511
Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
Diabetes and cardiovascular risk factors: the Framingham study
Kannel, W. B., & McGee, D. L. (1979) · Circulation · doi:10.1161/01.cir.59.1.8 · Cited by 1,317
Ridker, P. M., Hennekens, C. H., Roitman-Johnson, B., Stampfer, M. J., & Allen, J. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09032-6 · Cited by 1,229
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Verma, S., Wang, C.-H., Li, S.-H., Dumont, A. S., Fedak, P. W. M., Badiwala, M. V., Dhillon, B., Weisel, R. D., Li, R.-K., Mickle, D. A. G., et al. (2002) · Circulation · doi:10.1161/01.cir.0000029802.88087.5e · Cited by 1,054
C-Reactive Protein and the Risk of Developing Hypertension
Sesso, H. D. (2003) · JAMA · doi:10.1001/jama.290.22.2945 · Cited by 1,004
Griendling, K. K., Sorescu, D., Lassègue, B., & Ushio-Fukai, M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2175 · Cited by 955
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Self-citationHaffner, S. M., Greenberg, A. S., Weston, W. M., Chen, H., Williams, K., & Freed, M. I. (2002) · Circulation · doi:10.1161/01.cir.0000025403.20953.23 · Cited by 884
Ylä-Herttuala, S., Lipton, B. A., Rosenfeld, M. E., Särkioja, T., Yoshimura, T., Leonard, E. J., Witztum, J. L., & Steinberg, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5252 · Cited by 872
Venugopal, S. K., Devaraj, S., Yuhanna, I., Shaul, P., & Jialal, I. (2002) · Circulation · doi:10.1161/01.cir.0000033116.22237.f9 · Cited by 853
Zwaka, T. P., Hombach, V., & Torzewski, J. (2001) · Circulation · doi:10.1161/01.cir.103.9.1194 · Cited by 845
Pasceri, V., Chang, J., Willerson, J. T., & Yeh, E. T. H. (2001) · Circulation · doi:10.1161/01.cir.103.21.2531 · Cited by 831
Novel Clinical Markers of Vascular Wall Inflammation
Blake, G. J., & Ridker, P. M. (2001) · Circulation Research · doi:10.1161/hh2101.099270 · Cited by 754
Blood Pressure and Inflammation in Apparently Healthy Men
Chae, C. U., Lee, R. T., Rifai, N., & Ridker, P. M. (2001) · Hypertension · doi:10.1161/01.hyp.38.3.399 · Cited by 716
Stehouwer, C. D. A., Gall, M.-A., Twisk, J. W. R., Knudsen, E., Emeis, J. J., & Parving, H.-H. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1157 · Cited by 652
Devaraj, S., Xu, D. Y., & Jialal, I. (2003) · Circulation · doi:10.1161/01.cir.0000052617.91920.fd · Cited by 648
Reactive oxygen species in vascular biology: implications in hypertension
Touyz, R. M., & Schiffrin, E. L. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0696-7 · Cited by 646
Self-citationVerma, S., Li, S.-H., Badiwala, M. V., Weisel, R. D., Fedak, P. W. M., Li, R.-K., Dhillon, B., & Mickle, D. A. G. (2002) · Circulation · doi:10.1161/01.cir.0000015126.83143.b4 · Cited by 634
Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590
Self-citationTorzewski, M., Rist, C., Mortensen, R. F., Zwaka, T. P., Bienek, M., Waltenberger, J., Koenig, W., Schmitz, G., Hombach, V., & Torzewski, J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2094 · Cited by 581
CD40 Signaling and Plaque Instability
Schönbeck, U., & Libby, P. (2001) · Circulation Research · doi:10.1161/hh2401.101272 · Cited by 566
Stehouwer, C. A., Zeldenrust, G. C., den Ottolander, G. H., Hackeng, W. H. L., Donker, A. J. M., & Nauta, J. J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)91401-s · Cited by 560
p22phox mRNA Expression and NADPH Oxidase Activity Are Increased in Aortas From Hypertensive Rats
Fukui, T., Ishizaka, N., Rajagopalan, S., Laursen, J. B., Capers, Q., Taylor, W. R., Harrison, D. G., de Leon, H., Wilcox, J. N., & Griendling, K. K. (1997) · Circulation Research · doi:10.1161/01.res.80.1.45 · Cited by 553
C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle
Wang, C.-H., Li, S.-H., Weisel, R. D., Fedak, P. W. M., Dumont, A. S., Szmitko, P., Li, R.-K., Mickle, D. A. G., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000061916.95736.e5 · Cited by 545
Xiao, L., & Harrison, D. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.01.013 · Cited by 545
Vaughan, D. E., Lazos, S. A., & Tong, K. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117809 · Cited by 530
Verma, S., Kuliszewski, M. A., Li, S.-H., Szmitko, P. E., Zucco, L., Wang, C.-H., Badiwala, M. V., Mickle, D. A. G., Weisel, R. D., Fedak, P. W. M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127577.63323.24 · Cited by 525
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., & Michel, J.-B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 517
Han, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E. J., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2016 · Cited by 513
Aukrust, P., Müller, F., Ueland, T., Berget, T., Aaser, E., Brunsvig, A., Solum, N. O., Forfang, K., Frøland, S. S., & Gullestad, L. (1999) · Circulation · doi:10.1161/01.cir.100.6.614 · Cited by 506
Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive Rats
Rocha, R., Chander, P. N., Khanna, K., Zuckerman, A., & Stier, C. T. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.451 · Cited by 496
Hernández-Presa, M., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz-Ortega, M., & Egido, J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1532 · Cited by 494
C-reactive protein and the risk of developing hypertension
Sesso, H. D., Buring, J. E., Rifai, N., Blake, G. J., Gaziano, J. M., & Ridker, R. M. (2004) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.02.025 · Cited by 430
Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative Stress
Virdis, A., Neves, M. F., Amiri, F., Viel, E., Touyz, R. M., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/01.hyp.0000034738.79310.06 · Cited by 399
Self-citationEffect of Lifestyle Modification on Adipokine Levels in Obese Subjects with Insulin Resistance
Monzillo, L. U., Hamdy, O., Horton, E. S., Ledbury, S., Mullooly, C., Jarema, C., Porter, S., Ovalle, K., Moussa, A., & Mantzoros, C. S. (2003) · Obesity Research · doi:10.1038/oby.2003.144 · Cited by 397
Soluble CD40L: Risk Prediction After Acute Coronary Syndromes
Varo, N., de Lemos, J. A., Libby, P., Morrow, D. A., Murphy, S. A., Nuzzo, R., Gibson, C. M., Cannon, C. P., Braunwald, E., & Schönbeck, U. (2003) · Circulation · doi:10.1161/01.cir.0000088521.04017.13 · Cited by 384
Thorand, B., Löwel, H., Schneider, A., Kolb, H., Meisinger, C., Fröhlich, M., & Koenig, W. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.93 · Cited by 368
De Ciuceis, C., Amiri, F., Brassard, P., Endemann, D. H., Touyz, R. M., & Schiffrin, E. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000181743.28028.57 · Cited by 350
Self-citationAmiri, F., Virdis, A., Neves, M. F., Iglarz, M., Seidah, N. G., Touyz, R. M., Reudelhuber, T. L., & Schiffrin, E. L. (2004) · Circulation · doi:10.1161/01.cir.0000144462.08345.b9 · Cited by 346
Self-citationBlood Pressure, C-Reactive Protein, and Risk of Future Cardiovascular Events
Blake, G. J., Rifai, N., Buring, J. E., & Ridker, P. M. (2003) · Circulation · doi:10.1161/01.cir.0000104566.10178.af · Cited by 336
Li, L., Fink, G. D., Watts, S. W., Northcott, C. A., Galligan, J. J., Pagano, P. J., & Chen, A. F. (2003) · Circulation · doi:10.1161/01.cir.0000051459.74466.46 · Cited by 317
Savoia, C., & Schiffrin, E. L. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.mnh.0000203189.57513.76 · Cited by 314
Self-citationVascular endothelin in hypertension
Schiffrin, E. L. (2005) · Vascular Pharmacology · doi:10.1016/j.vph.2005.03.004 · Cited by 305
Self-citationKoh, K. K., Quon, M. J., Han, S. H., Chung, W.-J., Ahn, J. Y., Seo, Y.-H., Kang, M. H., Ahn, T. H., Choi, I. S., & Shin, E. K. (2004) · Circulation · doi:10.1161/01.cir.0000143085.86697.13 · Cited by 279
Role of NAD(P)H Oxidase in Angiotensin II–Induced JAK/STAT Signaling and Cytokine Induction
Schieffer, B., Luchtefeld, M., Braun, S., Hilfiker, A., Hilfiker-Kleiner, D., & Drexler, H. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1195 · Cited by 273
Touyz, R. M., Yao, G., & Schiffrin, E. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000069236.27911.68 · Cited by 270
Self-citationDeo, R., Khera, A., McGuire, D. K., Murphy, S. A., de P. Meo Neto, J., Morrow, D. A., & de Lemos, J. A. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.047 · Cited by 269
Takeya, M., Yoshimura, T., Leonard, E. J., & Takahashi, K. (1993) · Human Pathology · doi:10.1016/0046-8177(93)90166-e · Cited by 268
Rohde, L. E., Lee, R. T., Rivero, J., Jamacochian, M., Arroyo, L. H., Briggs, W., Rifai, N., Libby, P., Creager, M. A., & Ridker, P. M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.11.1765 · Cited by 260
Endothelin Antagonism on Aldosterone-Induced Oxidative Stress and Vascular Remodeling
Pu, Q., Neves, M. F., Virdis, A., Touyz, R. M., & Schiffrin, E. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000078357.92682.ec · Cited by 255
Self-citationSchiffrin, E. L., & Touyz, R. M. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00262.2004 · Cited by 253
Self-citationFesta, A., Hanley, A. J. G., Tracy, R. P., D’Agostino, R., & Haffner, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000091339.70120.53 · Cited by 232
Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients
Koh, K. K., Ahn, J. Y., Han, S. H., Kim, D. S., Jin, D. K., Kim, H. S., Shin, M.-S., Ahn, T. H., Choi, I. S., & Shin, E. K. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00846-5 · Cited by 225
Elevated Levels of Interleukin-18 Predict the Development of Type 2 Diabetes
Thorand, B., Kolb, H., Baumert, J., Koenig, W., Chambless, L., Meisinger, C., Illig, T., Martin, S., & Herder, C. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2932 · Cited by 216
Marx, N., Imhof, A., Froehlich, J., Siam, L., Ittner, J., Wierse, G., Schmidt, A., Maerz, W., Hombach, V., & Koenig, W. (2003) · Circulation · doi:10.1161/01.cir.0000069272.06194.91 · Cited by 215
Fiebeler, A., Schmidt, F., Müller, D. N., Park, J.-K., Dechend, R., Bieringer, M., Shagdarsuren, E., Breu, V., Haller, H., & Luft, F. C. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.787 · Cited by 213
Harada, E., Yoshimura, M., Yasue, H., Nakagawa, O., Nakagawa, M., Harada, M., Mizuno, Y., Nakayama, M., Shimasaki, Y., Ito, T., et al. (2001) · Circulation · doi:10.1161/01.cir.104.2.137 · Cited by 211
Effect of statins on C-reactive protein in patients with coronary artery disease
Strandberg, T. E., Vanhanen, H., & Tikkanen, M. J. (1999) · The Lancet · doi:10.1016/s0140-6736(05)76154-7 · Cited by 209
Touyz, R. M., Yao, G., Viel, E., Amiri, F., & Schiffrin, E. L. (2004) · Journal of Hypertension · doi:10.1097/00004872-200406000-00015 · Cited by 197
Self-citationHerbert Haught, W., Mansour, M., Rothlein, R., Kishimoto, T. K., Mainolfi, E. A., Hendricks, J. B., Hendricks, C., & Mehta, J. L. (1996) · American Heart Journal · doi:10.1016/s0002-8703(96)90383-x · Cited by 190
Trøseid, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.12.006 · Cited by 187
Iglarz, M., Touyz, R. M., Amiri, F., Lavoie, M.-F., Diep, Q. N., & Schiffrin, E. L. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000047447.67827.cd · Cited by 183
Self-citationKoh, K. K., Han, S. H., Quon, M. J., Yeal Ahn, J., & Shin, E. K. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1419 · Cited by 182
Wæhre, T., Yndestad, A., Smith, C., Haug, T., Tunheim, S. H., Gullestad, L., Frøland, S. S., Semb, A. G., Aukrust, P., & Damås, J. K. (2004) · Circulation · doi:10.1161/01.cir.0000125700.33637.b1 · Cited by 165
Koh, K. K., Quon, M. J., Han, S. H., Ahn, J. Y., Jin, D., Kim, H. S., Kim, D. S., & Shin, E. K. (2005) · Hypertension · doi:10.1161/01.hyp.0000166722.91714.ba · Cited by 164
Ammarguellat, F., Gannon, P. O., Amiri, F., & Schiffrin, E. L. (2002) · Hypertension · doi:10.1161/hy0202.103481 · Cited by 163
Self-citationMüller, D. N., Mervaala, E. M. A., Schmidt, F. H., Park, J.-K., Dechend, R., Genersch, E., Breu, V., Löffler, B., Ganten, D., Schneider, W., et al. (2000) · Hypertension · doi:10.1161/01.hyp.36.2.282 · Cited by 158
Oxidative Stress Increases Endothelin-1 Synthesis in Human Coronary Artery Smooth Muscle Cells
Kahler, J. P., Ewert, A., Weckmüller, J., Stobbe, S., Mittmann, C., Köster, R., Paul, M., Meinertz, T., & Münzel, T. F. (2001) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200107000-00006 · Cited by 157
Zouki, C., Beauchamp, M., Baron, C., & Filep, J. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119561 · Cited by 152
Valsartan, Blood Pressure Reduction, and C-Reactive Protein: Primary Report of the Val-MARC Trial
Ridker, P. M., Danielson, E., Rifai, N., & Glynn, R. J. (2006) · Hypertension · doi:10.1161/01.hyp.0000226046.58883.32 · Cited by 148
Waßmann, S., Hilgers, S., Laufs, U., Böhm, M., & Nickenig, G. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000022847.38083.b6 · Cited by 144
Barzilay, J. I., Peterson, D., Cushman, M., Heckbert, S. R., Cao, J. J., Blaum, C. S., Tracy, R. P., Klein, R., & Herrington, D. M. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.03.022 · Cited by 142
Fischer, C. P., Perstrup, L. B., Berntsen, A., Eskildsen, P. C., & Pedersen, B. K. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.07.008 · Cited by 141
Aukrust, P., Berge, R. K., Ueland, T., Aaser, E., Damås, J. K., Wikeby, L., Brunsvig, A., Müller, F., Forfang, K., Frøland, S. S., et al. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01110-4 · Cited by 141
Antiinflammatory and Antiarteriosclerotic Effects of Pioglitazone
Ishibashi, M., Egashira, K., Hiasa, K., Inoue, S., Ni, W., Zhao, Q. D., Usui, M., Kitamoto, S., Ichiki, T., & Takeshita, A. (2002) · Hypertension · doi:10.1161/01.hyp.0000036396.64769.c2 · Cited by 141
Engström, G., Janzon, L., Berglund, G. L., Lind, P., Stavenow, L., Hedblad, B., & Lindgärde, F. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000041842.43905.f3 · Cited by 136
Wegge, J. K., Roberts, C. K., Ngo, T. H., & Barnard, R. J. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.016 · Cited by 130
Sanz‐Rosa, D., Oubiña, M. P., Cediel, E., Heras, N. D. L., Vegazo, O., Jiménez, J., Lahera, V., & Cachofeiro, V. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01061.2003 · Cited by 129
Blanco‐Rivero, J., Cachofeiro, V., Lahera, V., Aras‐López, R., Márquez‐Rodas, I., Salaíces, M., Xavier, F. E., Ferrer, M., & Balfagón, G. (2005) · Hypertension · doi:10.1161/01.hyp.0000171479.36880.17 · Cited by 126
Semb, A. G., van Wissen, S., Ueland, T., Smilde, T. J., Wæhre, T., Trip, M. D., Frøland, S. S., Kastelein, J. J. P., Gullestad, L. L., Pedersen, T. R., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02718-3 · Cited by 117
Effect of Aldosterone and Mineralocorticoid Receptor Blockade on Vascular Inflammation
Joffe, H. V., & Adler, G. K. (2005) · Heart Failure Reviews · doi:10.1007/s10741-005-2346-0 · Cited by 114
Kalinina, N., Agrotis, A., Tararak, E. M., Antropova, Y., Kanellakis, P., Ilyinskaya, O. P., Quinn, M. T., Smirnov, V. N., & Bobik, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000040222.02255.0f · Cited by 112
Koh, K. K., Son, J. W., Ahn, J. Y., Jin, D., Kim, H. S., Choi, Y. M., Kim, D. S., Jeong, E.-M., Park, G. S., Choi, I. S., et al. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000030997.02059.bb · Cited by 103
Anti-inflammatory and metabolic effects of candesartan in hypertensive patients
Koh, K. K., Quon, M. J., Han, S. H., Chung, W., Lee, Y., & Shin, E. K. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.07.040 · Cited by 95
Schiffrin, E. L., Gutkowska, J., & Genest, J. (1984) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1984.246.4.h608 · Cited by 86
Self-citationObisesan, T. O., Leeuwenburgh, C., Phillips, T., Ferrell, R. E., Phares, D. A., Prior, S. J., & Hagberg, J. M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000140060.13203.22 · Cited by 83
Weight Reduction Decreases Soluble Cellular Adhesion Molecules In Obese Women
Ito, H., Ohshima, A., Inoue, M., Ohto, N., Nakasuga, K., Kaji, Y., Maruyama, T., & Nishioka, K. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03672.x · Cited by 82
Koh, K. K., Schenke, W. H., Waclawiw, M. A., Csákó, G., & Cannon, R. O. (2002) · Circulation · doi:10.1161/01.cir.0000013837.81710.da · Cited by 78
Sidhu, J. S., Cowan, D., & Kaski, J. C. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.051 · Cited by 73
Diabetes and hypertension physiopathology and therapeutics
Contreras, F., Rivera, M., Vásquez, J. M. R., la Parte, M. D., & Velasco, M. (2000) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1000983 · Cited by 71
Preston, R. A., Ledford, M. R., Materson, B. J., Baltodano, N. M., Memon, A., & Alonso, A. B. (2002) · Journal of Hypertension · doi:10.1097/00004872-200205000-00021 · Cited by 68
Koh, K. K., Ahn, J. Y., Han, S. H., Jin, D., Kim, H. S., Lee, K. C., Shin, E. K., & Sakuma, I. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.033 · Cited by 66
Niemann-Jönsson, A., Dimayuga, P. C., Jovinge, S. V., Calara, F., Ares, M. P. S., Fredrikson, G. N., & Nilsson, J. Å. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.10.2205 · Cited by 65
Koh, K. K., Han, S. H., Chung, W., Ahn, J. Y., Jin, D., Kim, H. S., Park, G. S., Kang, W. C., Ahn, T. H., & Shin, E. K. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.02.050 · Cited by 57
Marchesi, S., Lupattelli, G., Lombardini, R., Roscini, A. R., Siepi, D., Vaudo, G., Pirro, M., Sinzinger, H. F., Schillaci, G., & Mannarino, E. (2003) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.0269-4727.2003.00512.x · Cited by 49
Schiffrin, E. L., & Touyz, R. M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000069907.12357.7e · Cited by 49
Self-citationInhibition of the renin angiotensin system: Implications for the endothelium
Savoia, C., & Schiffrin, E. L. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0060-5 · Cited by 47
Self-citationFiedel, B. A., & Gewurz, H. (1976) · PubMed · Cited by 45
Simvastatin Combined With Ramipril Treatment in Hypercholesterolemic Patients
Koh, K. K., Son, J. W., Ahn, J. Y., Kim, D. S., Jin, D. K., Kim, H. S., Han, S. H., Seo, Y.-H., Chung, W.-J., Kang, W. C., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000133310.42762.25 · Cited by 45
Vascular effects of diet and statin in hypercholesterolemic patients
Koh, K. K., Son, J. W., Ahn, J. Y., Jin, D., Kim, H. S., Choi, Y. M., Ahn, T. H., Kim, D. S., & Shin, E. K. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.05.018 · Cited by 44
Trevelyan, J., Brull, D. J., Needham, E. W., Montgomery, H., Morris, A. G., & Mattu, R. K. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.05.017 · Cited by 41
Rosei, E. A., Morelli, P., & Rizzoni, D. (2005) · Blood Pressure · doi:10.1080/08037050510034257 · Cited by 29
Pro-inflammatory properties for thiazolidinediones
Desmet, C. J., Warzée, B., Gosset, P., Melotte, D., Rongvaux, A., Gillet, L., Fiévez, L., Seumois, G., Vanderplasschen, A. F. C., Staels, B., et al. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.09.017 · Cited by 28
Effects of C-Reactive Protein on Platelet Function
Fiedel, B. A., & Gewurz, H. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.117.4.1073 · Cited by 24
Ando, H., JEZOVA, M., Zhou, J., & Saavedra, J. M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1296.043 · Cited by 22
Roberts, C. K., Wegge, J. K., Ngo, T. H., & Barnard, R. J. (2003) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200305001-00583 · Cited by 3
Research works printed but not linked: 1
- Schöbeck, 2004, Inflammation, immunity, and HMG-CoA reductase inhibitors statins as anti-inflammatory agents?, Circulation, 109, II18
Cited by
Inflammation in Fear- and Anxiety-Based Disorders: PTSD, GAD, and Beyond
Michopoulos, V., Powers, A., Gillespie, C. F., Ressler, K. J., & Jovanovic, T. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.146 · Cited by 786
“…and blockers (ARBs) in the treatment of PTSD, as these classes of pharmacological agents are effective in managing cardio-metabolic disease that is highly co-morbid with PTSD. ACE-I/ARBs are typically prescribed to decrease blood pressure and sympathetic activity (Savoia and Schiffrin, 2007).”
BackgroundDiabetes and Hypertension: Is There a Common Metabolic Pathway?
Cheung, B. M. Y., & Li, C. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0227-2 · Cited by 576
“stress [49].”
Kell, D. B. (2009) · BMC Medical Genomics · doi:10.1186/1755-8794-2-2 · Cited by 554
“inflammatory in nature [678-686], is related to the”
BackgroundImpaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus
Levy, B. I., Schiffrin, E. L., Mourad, J.-J., Agostini, D., Vicaut, E., Safar, M. E., & Struijker-Boudier, H. A. J. (2008) · Circulation · doi:10.1161/circulationaha.107.763730 · Cited by 470
Self-citationEndothelial Dysfunction in Hypertension: Current Concepts and Clinical Implications
Gallo, G., Volpe, M., & Savoia, C. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.798958 · Cited by 446
“Essential hypertension is characterized by functional and structural alterations in resistance arteries which lead to increased peripheral vascular resistance (7).”
BackgroundSelf-citation
Metadata
- Authors
- Savoia, C., & Schiffrin, E. L.
- Affiliations
- Jewish General Hospital (CA)
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2007-03-01
- Volume
- 112
- Issue
- 7
- Pages
- 375-384
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1975582897
- Cited by
- 326
- References
- 129
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 8 · 2023: 7 · 2022: 13 · 2021: 10 · 2020: 21 · 2019: 14 · 2018: 15 · 2017: 20 · 2016: 18 · 2015: 24 · 2014: 21 · 2013: 23 · 2012: 21
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Science (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- vascular inflammation, hypertension, type 2 diabetes, angiotensin II, oxidative stress, NF-κB, endothelial dysfunction, cardiovascular risk, C-reactive protein, chemokines, adhesion molecules, renin-angiotensin system, blood pressure reduction, lifestyle modification
- MeSH terms
- Aldosterone, Angiotensin II, Diabetes Mellitus, Type 2, Humans, Hypertension, Renin-Angiotensin System, Vasculitis, Cell Adhesion Molecules, Cytokines, NF-kappa B, Disease Progression, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.